Amarantus Bioscience Holdings Inc (AMBS)

[Calm68]

At this time last year AMBS had pretty much nothing except some MANF science and a lot of debt. No functional team, no facilities, no one on board, no money, no potential for revenues at any point in the foreseeable future. At this time AMBS has a credible plan for revenue in the next 10 - 12 months with Lympro, substantially reduced debt, funding for 2-4 more quarters, a top notch team to execute its plan, an A++ facility right in the middle of the UC/Big Pharma joint incubation.

Yes there was dilution and no AMBS isn't bigger than Amgen. Still, in any reality based world this has been a superb year for Gerald and AMBS. Investors should be happy. Speculators, flippers, shorts, and folks who got overextended are making noise.

All imo